The Aperlena Verdict
Open raceNo supplier dominates: 21 different companies have won the last 39 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected wait for the award decision
- 7 days
- from 39 past awards
Based on 39 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe contracting authority Fondazione IRCCS Istituto Nazionale dei Tumori is procuring the medicinal product NEXAVAR 200 MG under a procedure for pharmaceuticals. The award method is direct award following the collection of quotations. The notice is categorised within the pharmaceutical products merchandise category and the procedure status is published. The supply concerns the named anticancer medicine at the stated 200 mg strength.
Key points
- Status at the source
- Pubblicata
- Procedure
- NEXAVAR 200 MG
- Type of contract
- Procedura per farmaci
- Reference
- non pubblicato (mascherato nella fonte)
Original text
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Direct award: the buyer chose the supplier without a call for bids.
- The notice is written in Italian.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: ARIA Sintel - Regione Lombardia e-procurement
Always verify details on the official notice.
Report an error in this notice
Last verified against ARIA Sintel - Regione Lombardia e-procurement 11 hours ago
Expected award price
- likely award for this notice, from its published estimate of €39,691
- €15,479 to €30,562
Comparable awards in this country and sector came in at a median of 56% of their published estimate, half of them between 39% and 77%, based on 1,120 awards of the last 3 years.
Each award is compared with the estimate of the same lots, framework agreements excluded. A published estimate may include options and renewals, so an award under it is not always a discount.
What this buyer has paid before
Based on 39 comparable contracts this buyer awarded in this sector over the last 4 years.
- This notice
- €39,691
- Median award
- €1,437
- Middle half of past awards
- €545 to €2,225
The estimate is larger than three in four past awards.
Most recent awards
- Direct award - Cell culture plates - Merck S.p.A. €461
- Direct award - Graduated cylinder - Biosigma S.p.A. €152
- Complete nutritional mixture for hyperproteic enteral nutrition (5-7 G/100ML) €1,980
- Direct award of reagents/antibodies/plastics Life Technologies €2,919
- Direct award - Supply of reagents - Merck Life Science €464
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
- notices in the register
- 167
- awards
- 43
- awarded in total
- €1.8M
Who wins its contracts
Moderately concentrated- different companies won its awards
- 25
- of the awards went to the three most frequent winners
- 40%
- of its calls state an estimated value
- 39%
Based on 43 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Life Technologies Italia Fil. Life Technologies Europe BV | 9 | €21,927 | Sep 2026 |
| Merck Life Science S.r.l. | 6 | €10,406 | Oct 2026 |
| D.I.D. DIAGNOSTIC INTERNATIONAL DISTRIBUTION SPA | 2 | €3,007 | Sep 2026 |
| S.I.A.L. SRL | 2 | €2,557 | Sep 2026 |
| Aurogene Srl | 2 | €2,164 | Sep 2026 |
Based on 39 awards with a linked company profile over the last 5 years.
14 open tenders right now
- CAMPOVERDE 004 1 day left
- EUROCLONE 005 - Supply of diagnostic devices 1 day left
- ILLUMINA 006 1 day left
Market context
Larger than 20% of the open notices in Medical equipment & pharmaceuticals across Europe.
- open now in Medical equipment & pharmaceuticals
- 10,879
- median open notice
- €143,348
Who wins in this market
Many suppliersItaly · Medical equipment & pharmaceuticals
- different companies won awards here
- 1,690
- of the awards went to the three most frequent winners
- 2%
- winners of the last 12 months were new here
- 1,405 of 1,463
- buyers awarded contracts here
- 388
Based on 2,551 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.9
- of those lots received a single tender
- 38%
- of the awards went to companies based in another country
- 1%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
3
days left
€13,200
est. value
3
days left
€24,480
est. value
3
days left
€29,000
est. value
Awarded before
Never miss a tender like this
2,224 new notices in Medical equipment & pharmaceuticals in Italy in the last 7 days. Get an email when new ones appear. Free.
Set up my alert